For the upcoming #LCSM chat on Thursday, 5/31 at 8 PM Eastern (5 PM Pacific), we’re going to preview some of the key abstracts in lung cancer and mesothelioma that will be presented at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago in early June. This meeting brings together over 38,000 cancer specialists every year to review thousands of presentations. Nobody can see it all, and one important aspect of not being overwhelmed is knowing what should be the focus of your attention.

Dr. Jack West has compiled two lists of abstracts he believes will reveal important findings for the thoracic oncology community. We’ll be discussing these and any other abstracts you might find interesting. Alas, ASCO begins June 1, so many thoracic oncology professionals, advocates, and patients will be en route to the conference at the time of the chat.  If you won’t be able to join the chat and have an abstract you think should be discussed, please tweet it to @lcsmchat sometime before the chat so we can include it.

This won’t be the usual #LCSM Chat question and answer format. Instead, we’ll post an abstract and spend a few minutes discussing it before moving onto the next abstract.

Here are two lists of top lung cancer and mesothelioma abstracts at ASCO 2018 that will get us started:

My Top 5 ASCO 2018 Abstracts in Stage I-III NSCLC, Small Cell Lung Cancer, & Mesothelioma  (OncologyTube video) by Jack West

My Top 5 ASCO 2018 Abstracts in Advanced NSCLC  (OncologyTube video) by Jack West

Please remember to include #LCSM in ALL your tweets so the other chat participants can see them. If you need a refresher, read our primer on participating in the chat . Hope you’ll join us!